An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes

J.S. Wells; C. Wang; K. Dolgin; R. Kayyali

doi:10.1093/ijpp/riad021.043

An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes

J.S. Wells, C. Wang, K. Dolgin, R. Kayyali

Research output: Contribution to conference › Lecture / Speech › peer-review

Original language	English
DOIs	https://doi.org/10.1093/ijpp/riad021.043
Publication status	Accepted/In press - 9 Jan 2023
Event	Health Services Research and Pharmacy Practice (HSRPP) Conference 2023 : Partnerships in Healthcare: Advancing Sustainable Medicines Optimisation - Bradford, U.K. Duration: 17 Apr 2023 → 18 Apr 2023

Conference

Conference	Health Services Research and Pharmacy Practice (HSRPP) Conference 2023 : Partnerships in Healthcare: Advancing Sustainable Medicines Optimisation
Period	17/04/23 → 18/04/23

Bibliographical note

Note: An abstract of this oral presentation was published in International Journal of Pharmacy Practice, Volume 31, Issue Supplement 1, April 2023, pp. i36-i37.

Keywords

Allied health professions and studies

Access to Document

10.1093/ijpp/riad021.043

Wells-J-53060-AAMAccepted author manuscript, 161 KBLicence: Unspecified

https://doi.org/10.1093/ijpp/riad021.043

An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes
Wells, J. (Recipient) & Wang, C. (Recipient), 2023
Prize

Cite this

Wells, J. S., Wang, C., Dolgin, K., & Kayyali, R. (Accepted/In press). An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes. Health Services Research and Pharmacy Practice (HSRPP) Conference 2023 : Partnerships in Healthcare: Advancing Sustainable Medicines Optimisation. https://doi.org/10.1093/ijpp/riad021.043

Wells, J.S. ; Wang, C. ; Dolgin, K. et al. / An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes. Health Services Research and Pharmacy Practice (HSRPP) Conference 2023 : Partnerships in Healthcare: Advancing Sustainable Medicines Optimisation.

@conference{a2deac13c6064713ba41df9fec1878ad,

title = "An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes",

keywords = "Allied health professions and studies",

author = "J.S. Wells and C. Wang and K. Dolgin and R. Kayyali",

note = "Note: An abstract of this oral presentation was published in International Journal of Pharmacy Practice, Volume 31, Issue Supplement 1, April 2023, pp. i36-i37.; Health Services Research and Pharmacy Practice (HSRPP) Conference 2023 : Partnerships in Healthcare: Advancing Sustainable Medicines Optimisation ; Conference date: 17-04-2023 Through 18-04-2023",

year = "2023",

month = jan,

day = "9",

doi = "10.1093/ijpp/riad021.043",

language = "English",

}

Wells, JS, Wang, C, Dolgin, K & Kayyali, R 2023, 'An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes', Health Services Research and Pharmacy Practice (HSRPP) Conference 2023 : Partnerships in Healthcare: Advancing Sustainable Medicines Optimisation, 17/04/23 - 18/04/23. https://doi.org/10.1093/ijpp/riad021.043

An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes. / Wells, J.S.; Wang, C.; Dolgin, K. et al.
2023. Health Services Research and Pharmacy Practice (HSRPP) Conference 2023 : Partnerships in Healthcare: Advancing Sustainable Medicines Optimisation.

Research output: Contribution to conference › Lecture / Speech › peer-review

TY - CONF

T1 - An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes

AU - Wells, J.S.

AU - Wang, C.

AU - Dolgin, K.

AU - Kayyali, R.

N1 - Note: An abstract of this oral presentation was published in International Journal of Pharmacy Practice, Volume 31, Issue Supplement 1, April 2023, pp. i36-i37.

PY - 2023/1/9

Y1 - 2023/1/9

KW - Allied health professions and studies

U2 - 10.1093/ijpp/riad021.043

DO - 10.1093/ijpp/riad021.043

M3 - Lecture / Speech

T2 - Health Services Research and Pharmacy Practice (HSRPP) Conference 2023 : Partnerships in Healthcare: Advancing Sustainable Medicines Optimisation

Y2 - 17 April 2023 through 18 April 2023

ER -

Wells JS, Wang C, Dolgin K, Kayyali R. An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes. 2023. Health Services Research and Pharmacy Practice (HSRPP) Conference 2023 : Partnerships in Healthcare: Advancing Sustainable Medicines Optimisation. doi: 10.1093/ijpp/riad021.043

An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes

Conference

Bibliographical note

Keywords

Access to Document

Prizes

An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with type 2 diabetes

Cite this